Literature DB >> 15122329

Connexin43 pseudogene is expressed in tumor cells and inhibits growth.

Mustapha Kandouz1, Andrew Bier, George D Carystinos, Moulay A Alaoui-Jamali, Gerald Batist.   

Abstract

Pseudogenes are classically thought of as nonfunctional DNA sequences due to their inability to be translated, or to produce a functional protein. Gap junctions, a multiprotein complex made of proteins called connexins, are involved in intercellular communication and are deregulated in many cancers. Connexin43 (Cx43) is the only connexin for which a pseudogene has been reported so far. The Cx43 pseudogene (PsiCx43) has all of the features of an expressed gene. We identified the presence of a PsiCx43 mRNA transcript in several cancer cell lines and in none of the normal mammary epithelial cells studied. Using an in vitro translation assay, we found that the PsiCx43 coding plasmid could be translated into a 43 kDa protein. This was further confirmed by expressing a PsiCx43-green fluorescence protein fusion protein in breast cancer MCF-7 cells. We then examined the functional significance of the PsiCx43. In both MTT growth and colony formation assays, significant growth inhibition was observed, a feature common to cells overexpressing the Cx43 gene. However, using a scrape-loading assay, we could not detect any effect on gap junctional intercellular communication. Based on our findings, PsiCx43 joins and enlarges the thus far restricted group of functionally transcribed and translated pseudogenes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122329     DOI: 10.1038/sj.onc.1207506

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

Review 1.  Long non-coding RNAs in cancer: implications for personalized therapy.

Authors:  Marianna Vitiello; Andrea Tuccoli; Laura Poliseno
Journal:  Cell Oncol (Dordr)       Date:  2014-08-12       Impact factor: 6.730

2.  Pseudogenes: Four Decades of Discovery.

Authors:  Leonardo Salmena
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Mycobacterium leprae: genes, pseudogenes and genetic diversity.

Authors:  Pushpendra Singh; Stewart T Cole
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

4.  Molecular dynamics and in vitro analysis of Connexin43: A new 14-3-3 mode-1 interacting protein.

Authors:  Darren J Park; Tracey A Freitas; Christopher J Wallick; Carrie V Guyette; Bonnie J Warn-Cramer
Journal:  Protein Sci       Date:  2006-10       Impact factor: 6.725

Review 5.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

6.  Identification and functional analysis of PCNA1 and PCNA-like1 genes of Phaseolus coccineus.

Authors:  Wojciech Strzalka; Anna Kaczmarek; Barbara Naganowska; Alicja Ziemienowicz
Journal:  J Exp Bot       Date:  2009-12-10       Impact factor: 6.992

7.  Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression.

Authors:  Zoe Redshaw; Alastair J Strain
Journal:  J Negat Results Biomed       Date:  2010-03-31

8.  Whole-genome tiling array analysis of Mycobacterium leprae RNA reveals high expression of pseudogenes and noncoding regions.

Authors:  Takeshi Akama; Koichi Suzuki; Kazunari Tanigawa; Akira Kawashima; Huhehasi Wu; Noboru Nakata; Yasunori Osana; Yasubumi Sakakibara; Norihisa Ishii
Journal:  J Bacteriol       Date:  2009-03-13       Impact factor: 3.490

9.  The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development.

Authors:  Jingyu Zhang; Xia Wang; Bing Chen; Zhifeng Xiao; Wenmei Li; Youyong Lu; Jianwu Dai
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

10.  Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors.

Authors:  Minjing Zou; Essa Y Baitei; Ali S Alzahrani; Futwan Al-Mohanna; Nadir R Farid; Brian Meyer; Yufei Shi
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.